Novak Djokovic Holds Primary Stake In Company Growing Covid Drug: CEO | Tennis Information

Serbian tennis superstar Novak Djokovic, not too long ago deported from Australia because of his coronavirus vaccine standing, is co-founder and majority shareholder of a biotech company growing a Covid remedy, the Danish corporate’s CEO stated Wednesday. “He is among the founders of my corporate we based in June 2020,” the manager government of QuantBioRes, Ivan Loncarevic, advised AFP. In line with data publicly to be had within the Danish industry sign in, 34-year-old Djokovic and his spouse, Jelena, in combination grasp a stake of 80 % in QuantBioRes, which employs a personnel of round 20 in Denmark, Slovenia, Australia and Britain.

“We purpose to broaden a brand new era to battle viruses and resistant micro organism and we made up our minds to make use of Covid as a exhibit,” Loncarevic stated.

“If we be triumphant with Covid, we will be able to be triumphant with different viruses.”

QuantBioRes is making plans to release scientific trials in the United Kingdom in the summertime, the CEO stated.

The unvaccinated males’s global primary flew out of Melbourne on Sunday after he failed in a last-gasp court docket bid to stick and play within the opening Grand Slam of the 12 months, the place he was once focused on a report 21st primary identify.

Promoted

His dramatic departure adopted a prolonged, high-stakes criminal fight between the athlete and Australian government that solid a depressing shadow over the event.

Contacted via AFP, Djokovic’s spokesman declined to remark at the tennis superstar’s stake within the Danish biotech company.